Martin Müller
- Infectious Diseases top 2%
- Molecular Biology
- Epidemiology
- Immunology
- Animal Science and Zoology top 5%
- Co-authors
- Martin Sebastian WinklerHeike Hofmann-WinklerStefan PöhlmannBernd JahrsdörferHans‐Martin JäckAlexander KlegerNadine KrügerAlexander S. Hahn
- Topics
- SARS-CoV-2 and COVID-19 Research (4 papers)Virus-based gene therapy research (3 papers)COVID-19 Clinical Research Studies (3 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Martin Müller
11 papers receiving 752 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Infectious Diseases 585
- Molecular Biology 174
- Epidemiology 137
- Immunology 120
- Animal Science and Zoology 98
Countries citing papers authored by Martin Müller
This map shows the geographic impact of Martin Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Müller more than expected).
Fields of papers citing papers by Martin Müller
This network shows the impact of papers produced by Martin Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Müller. The network helps show where Martin Müller may publish in the future.
Co-authorship network of co-authors of Martin Müller
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Müller. A scholar is included among the top collaborators of Martin Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Müller. Martin Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 13 | |
| 5 | SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesbreakdown → | 563 |
| 6 | 0 | |
| 7 | 31 | |
| 8 | 12 | |
| 9 | 28 | |
| 10 | 72 | |
| 11 | 28 | |
| 12 | [Cost-benefit analysis of the control and cure of enzootic bovine leukosis, described in the example of a selected territory]. | 2 |
About Martin Müller
Martin Müller is a scholar working on Infectious Diseases, Biophysics and Genetics, having authored 12 papers that have together received 764 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Virus-based gene therapy research (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (585 citations), Animal Science and Zoology (98 citations) and Modeling and Simulation (33 citations). Martin Müller has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Martin Sebastian Winkler, Heike Hofmann-Winkler, Stefan Pöhlmann, Bernd Jahrsdörfer, Hans‐Martin Jäck, Alexander Kleger, Nadine Krüger, Alexander S. Hahn, Luise Graichen and Alina Seidel. Their work appears in journals such as Cell, Virology and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.